Related content

A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice

By Zhang Helong   Yano Seiji   Miki Toyokazu   Goto Hisatsugu   Kanematsu Takanori   Muguruma Hiroaki   Uehara Hisanori   Sone Saburo  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292

By Furugaki Koh  

Clinical and Experimental Metastasis, Vol. 28, Iss. 7, 2011-10 ,pp. : 649-659

Springer Publishing Company

Access to resources Recommend Favorite

The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer

By Bayrak Suna  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 112-118

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

By                                

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 532-540

Spandidos Publications

Access to resources Recommend Favorite

A novel animal model for bone metastasis in human lung cancer

By                  

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 802-806

Spandidos Publications

Access to resources Recommend Favorite